A comprehensive view of Implantable Drug Delivery/Smart Pills. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Chemicals Industry Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Preclinical-stage biotech InSitu Biologics signs agreement with Mayo Clinic to develop InSitu’s prolonged-release drug delivery technology for anti-cancer therapeutics; the technology loads large doses of drugs for release over extended period

Global drug delivery devices market expected to hit US$124.8B by 2029, with CAGR growth of 5.6% from 2022-2029 driven by increase in chronic diseases, including diabetes; diabetes expected to affect 783 million people worldwide by 2045

Ashland's Viatel bioresorbable mPEG-PDLLA pharmaceutical excipient has been accepted into FDA Novel Excipient Review Pilot Program for drug formulations; Viatel is a polymeric carrier to deliver pharmaceuticals to targeted sites in the body

Celanese expands capabilities for pharmaceutical-grade polymers used in sustained-release drug implants and inserts; new 1,000-sq.-ft. cleanroom facility in Edmonton, Alberta, focuses on company's VitalDose EVA material in powder format

Global drug delivery system market projected to reach US$363.8B by 2030 with 6.1% CAGR growth from 2022 to 2030; growth driven by rising demand for biosimilars, vaccines, biologics, novel drug delivery systems

Ask us about our Chemicals Industry market view

Trending Chart

Interactive chart with headline count